United States: PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Goodwin Procter LLP

Mondaq

07 May 2024 0 shares 1 views

United States: PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Goodwin Procter LLP

Mondaq

Published 07 May 2024

On April 22, 2024, the PTAB issued final written decisions in IPR2023-00070 and IPR2023-00074, filed by Bluebird Bio on two patents related to recombinant lentiviral vectors...

Full Article

United States: IPR And PGR Statistics For Final Written Decisions Issued In March 2024 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

In March, the PTAB cancelled 458 (75.21%) instituted claims across 31 IPR and PGR Final Written Decisions...

Mondaq 06 May 2024

United States: PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Goodwin Procter LLP

United States: PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Goodwin Procter LLP

You might like

Related news coverage

United States: IPR And PGR Statistics For Final Written Decisions Issued In March 2024 - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Advertisement